Search

Your search keyword '"Peleg, Yonatan"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Peleg, Yonatan" Remove constraint Author: "Peleg, Yonatan"
27 results on '"Peleg, Yonatan"'

Search Results

1. C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First Two Years Post-Transplantation

2. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

3. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

4. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network

5. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

6. The Significance of Hematuria in Podocytopathies

9. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

12. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

14. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

15. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulopathy Network

17. Longitudinal Outcomes of COVID-19–Associated Collapsing Glomerulopathy and Other Podocytopathies

19. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy

21. Kidney Biopsy Findings in Patients with COVID-19

24. Directed Evolution of Scanning Unnatural-Protease-Resistant (SUPR) Peptides for in Vivo Applications

25. Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies

27. C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation.

Catalog

Books, media, physical & digital resources